BE1002256A3 - Medicaments. - Google Patents

Medicaments. Download PDF

Info

Publication number
BE1002256A3
BE1002256A3 BE8900222A BE8900222A BE1002256A3 BE 1002256 A3 BE1002256 A3 BE 1002256A3 BE 8900222 A BE8900222 A BE 8900222A BE 8900222 A BE8900222 A BE 8900222A BE 1002256 A3 BE1002256 A3 BE 1002256A3
Authority
BE
Belgium
Prior art keywords
drugs
sufotidine
administration
human
useful
Prior art date
Application number
BE8900222A
Other languages
English (en)
Inventor
Roger Stables
Keith Thomas Bunce
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of BE1002256A3 publication Critical patent/BE1002256A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

L'invention concerne la co-administration en médecine humaine ou vétérinaire d'un médicament anti-inflammatoire non-stéroïdique général et de sufotidine ou de l'un de ses sels physiologiquement acceptables. Les deux ingrédients actifs, qui peuvent être administrés séparément ou peuvent être combinés en une seule préparation, sont utiles dans le traitement des états inflammatoires.
BE8900222A 1988-03-04 1989-03-03 Medicaments. BE1002256A3 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888805268A GB8805268D0 (en) 1988-03-04 1988-03-04 Medicaments

Publications (1)

Publication Number Publication Date
BE1002256A3 true BE1002256A3 (fr) 1990-11-06

Family

ID=10632893

Family Applications (1)

Application Number Title Priority Date Filing Date
BE8900222A BE1002256A3 (fr) 1988-03-04 1989-03-03 Medicaments.

Country Status (12)

Country Link
JP (1) JP2834175B2 (fr)
KR (1) KR890014110A (fr)
AU (1) AU3098489A (fr)
BE (1) BE1002256A3 (fr)
DE (1) DE3906884A1 (fr)
DK (1) DK104489A (fr)
FR (1) FR2627985A1 (fr)
GB (2) GB8805268D0 (fr)
IT (1) IT8947714A0 (fr)
NL (1) NL8900525A (fr)
SE (1) SE8900752L (fr)
ZA (1) ZA891640B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO300260B1 (no) 1993-05-05 1997-05-05 Torgersen Hans & Soenn Bilbarnestol
MY164077A (en) * 1999-05-13 2017-11-30 Pharma Mar Sa Compositions and uses of et743 for treating cancer
ATE252887T1 (de) * 1999-09-24 2003-11-15 Alcon Inc Topische suspensionsformulierungen enthaltend ciprofloxacin und dexamethason
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
EP2344139A1 (fr) 2008-09-09 2011-07-20 AstraZeneca AB Procédé d'administration d'une composition pharmaceutique à un patient en ayant besoin
EA201290026A1 (ru) 2009-06-25 2012-07-30 Астразенека Аб Способ лечения пациента, имеющего риск развития язвы, связанной с приемом нестероидных противовоспалительных средств (nsaid)
BR112014016085A8 (pt) 2011-12-28 2017-07-04 Pozen Inc composições aprimoradas e métodos para distribuição de omeprazol mais ácido acetilsalicílico

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2075007A (en) * 1980-02-28 1981-11-11 Glaxo Group Ltd Heterocyclic derivatives
FR2512343A1 (fr) * 1981-09-04 1983-03-11 Glaxo Group Ltd Composition pharmaceutique contenant un medicament anti-inflammatoire systemique non steroidique et du 1-methyl-5- ( (3-( 3-1-piperidinylmethyl)phenoxy)propyl)amino)-1h-1,2,4-triazole-3-methanol ou un sel de ce compose acceptable pour l'usage pharmaceutique et procede de preparation de cette composition
GB2105193A (en) * 1981-09-04 1983-03-23 Glaxo Group Ltd Pharmaceutical compositions containing non-steroidal anti-inflammatory agents
WO1988008302A1 (fr) * 1987-04-24 1988-11-03 Abraham Sunshine Melanges contre la toux/le rhume comprenant des remedes d'antihistamine non sedative

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2075007A (en) * 1980-02-28 1981-11-11 Glaxo Group Ltd Heterocyclic derivatives
FR2512343A1 (fr) * 1981-09-04 1983-03-11 Glaxo Group Ltd Composition pharmaceutique contenant un medicament anti-inflammatoire systemique non steroidique et du 1-methyl-5- ( (3-( 3-1-piperidinylmethyl)phenoxy)propyl)amino)-1h-1,2,4-triazole-3-methanol ou un sel de ce compose acceptable pour l'usage pharmaceutique et procede de preparation de cette composition
GB2105193A (en) * 1981-09-04 1983-03-23 Glaxo Group Ltd Pharmaceutical compositions containing non-steroidal anti-inflammatory agents
WO1988008302A1 (fr) * 1987-04-24 1988-11-03 Abraham Sunshine Melanges contre la toux/le rhume comprenant des remedes d'antihistamine non sedative

Also Published As

Publication number Publication date
DK104489A (da) 1989-09-05
JP2834175B2 (ja) 1998-12-09
AU3098489A (en) 1989-09-07
IT8947714A0 (it) 1989-03-03
FR2627985A1 (fr) 1989-09-08
KR890014110A (ko) 1989-10-21
JPH01316319A (ja) 1989-12-21
SE8900752L (sv) 1989-09-05
ZA891640B (en) 1990-03-28
GB2216413A (en) 1989-10-11
SE8900752D0 (sv) 1989-03-03
GB8805268D0 (en) 1988-04-07
DE3906884A1 (de) 1989-09-14
DK104489D0 (da) 1989-03-03
GB8904879D0 (en) 1989-04-12
NL8900525A (nl) 1989-10-02

Similar Documents

Publication Publication Date Title
EA200300046A1 (ru) Быстро увеличивающаяся в объеме композиция для удерживания и контролированного выделения терапевтических агентов в желудке и лекарственные формы, включающие композицию
BR9909672A (pt) uso de um composto medicinal ativo no preparo de um medicamento para o tratamento de hipertensão
BR0009016A (pt) Composição de apomorfina e sildenafil
NO171145C (no) Fremgangsmaate for fremstilling av en fettemulsjon med et hydrofobt medikament
TR200000369T2 (tr) Romatizmal hastalıkların tedavisinde kullanılmak üzere kombine farmasötik preparatların üretilmesi.
DE3669106D1 (de) Pharmazeutische zusammensetzungen mit gehalt an flavanolignanen und phospholipiden als wirkstoffe.
RU95101385A (ru) Продукты, содержащие g-csf и tnf связующие протеина
KR970061244A (ko) 치매 치료용 약학 조성물
ES2139842T3 (es) Uso de la melatonina para tratar a pacientes que sufren drogodependencia.
BE1002256A3 (fr) Medicaments.
PT1027053E (pt) Metodo de prevencao de nefrotoxicidade provocada por ciclosporinas e tacrolimus
BE1002255A5 (fr) Medicaments.
BE1002295A5 (fr) Medicaments.
ES2052922T3 (es) Nucleosidos terapeuticos.
BE1002182A5 (fr) Compositions pharmaceutiques.
AR002727A1 (es) El uso de ridogrel para la fabricacion de un medicamento util para el tratamiento de enfermedades digestivas inflamatorias, una composicionfarmaceutica que comprende ridogrel y un procedimiento para preparar dicha composicion.
US4355029A (en) Combination therapy for rheumatoid arthritis
ATE91890T1 (de) Herstellung eines arzneimittels gegen arthritis und rheumatismus.
EP0402208B1 (fr) Association de vitamine A à dose physiologique et de différents principes actifs ayant une activité thérapeutique
HUP9901935A2 (hu) Gyógyszerek és terápiás szerek és más glikozaminoglikánok (GAG) dózisainak célbajuttatására alkalmas dóziskészlet
JP2752250B2 (ja) 鎮痛及び抗炎症作用を有する基礎治療剤
Jose et al. Levamisole in patients with recurrent herpes infection
KR910007528A (ko) 벤조디아제핀 및 페닐피릴케톤 유도체의 용도
JPH0251405B2 (fr)
RU2071342C1 (ru) Способ лечения цирротической формы туберкулеза легких

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: GLAXO GROUP LTD

Effective date: 19910331